News & Articles

New isotype-specific secondary antibodies promise improved signal detection and specificity in imaging

SelectScience reports on the top technologies launched at the American Association for Cancer Research (AACR) annual meeting, in Atlanta, USA

The tripartite mRNA technology has completed its phase 1b study for direct, intranodal injections in adjuvant melanoma patients

Learn how the latest next-generation automated assays are transforming our approach to drug discovery in the field of immuno-oncology

New research suggests that metal-based chemotherapies eliminate inhibitory components of the immune system

SelectScience is hosting two free CE-accredited events for healthcare professionals and laboratory scientists, but hurry - spots are filling up fast!

Multi-centre study published in New England Journal of Medicine suggests CAR-T therapy could improve outcome in B-cell lymphoma patients

From 3D tissue profiling to intelligent surgical tools, discover some of the latest innovations set to revolutionize diagnostics in cancer

Quantifying and targeting MDSCs, the ‘queen bee of the TME’, could overcome resistance to immunotherapy, Dr. R. J. Tesi tells SelectScience

Ready-to-use immunoassay kit designed to increase productivity

The importance of good secondary antibodies in understanding the effects of drug delivery vehicles

A celebration of the clinical laboratory products that have made the most difference to your lab work, plus we reveal our most popular clinical interviews of the past year

BD AbSeq assay enables deeper understanding of role individual cells play in the immune System

Innovations promise high quality antibodies, delivering confidence in reproducibility, standardization, improved workflow, and reduction in manual errors